Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2022 | 01-2022 | 10-2021 | 07-2021 | 06-2021 | |
| Operating Expenses | 3,873 | 2,557 | 3,584 | 2,306 | 1,390 |
| Operating Income | -3,873 | -2,557 | -3,584 | -2,306 | -1,390 |
| Interest Expense | 1 | 16 | 16 | 14 | 0 |
| Other Income | 4 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -3,869 | -2,573 | -3,600 | -2,320 | -1,390 |
| Net Income Continuous | -3,869 | -2,573 | -3,600 | -2,320 | 0 |
| Net Income | $-3,869 | $-2,573 | $-3,600 | $-2,320 | $-2,320 |
| EPS Basic Total Ops | -53.98 | -40.48 | -53.98 | -40.48 | N/A |
| EPS Basic Continuous Ops | -61.38 | -36.87 | -51.98 | -37.01 | N/A |
| EPS Diluted Total Ops | -53.98 | -40.48 | -53.98 | -40.48 | N/A |
| EPS Diluted Continuous Ops | -61.38 | -36.87 | -51.98 | -37.01 | N/A |
| EBITDA(a) | $-3,873 | $-2,557 | $-3,584 | $-2,306 | $-1,390 |